Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ionis Pharmaceuticals Inc (NASDAQ:IONS)

46.38
Delayed Data
As of May 26
 +0.03 / +0.06%
Today’s Change
19.59
Today|||52-Week Range
57.00
-3.03%
Year-to-Date

Today’s Trading

Previous close46.35
Today’s open46.76
Day’s range46.22 - 47.71
Volume1,170,626
Average volume (3 months)1,697,997
Market cap$5.7B
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)+2.70%
Earnings growth (this year)+52.31%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+22.18%
P/E ratioNM
Price/Sales16.69
Price/Book56.66

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA-0.05-0.23%
ALNYAlnylam Pharmaceutic...-3.70-5.32%
UTHRUnited Therapeutics ...+0.74+0.63%
RDYDr.Reddy's Laborator...-0.26-0.69%
Data as of 4:02pm ET, 05/26/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$346.6M
Annual profit (last year)-$86.6M
Net profit margin-24.97%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Stanley T. Crooke
Chief Operating Officer &
Director
B. Lynne Parshall
Corporate headquarters
Carlsbad, California

Forecasts